USACE's Buffalo District uses matrix teams to unite diverse roles and expertise, delivering solutions for the nation’s toughest infrastructure challenges.
See you in Spring 2026! *After submitting the entrance survey, you will receive information on accessing the event. Each person should submit their own entrance survey. Entering the Discord prior to ...
The FDA granted priority review for trastuzumab deruxtecan in combination with pertuzumab for first-line treatment of adults with unresectable or metastatic HER2-positive breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback